Maira Giulio, Anile Carmelo, Albanese Alessio, Cabezas Daniel, Pardi Flaminia, Vignati Andrea
Istituto di Neurochirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.
J Neurosurg. 2004 Mar;100(3):445-51. doi: 10.3171/jns.2004.100.3.0445.
The optimal approach for the surgical treatment of craniopharyngiomas is still debated. In all cases involving the sella turcica, the authors have exclusively used transsphenoidal surgery (TSS), assuming that this approach is less traumatic than an intracranial one. Moreover, TSS was also performed in some cases of purely suprasellar craniopharyngiomas. In this study the surgical indications and the results obtained in all patients who had undergone TSS were analyzed.
In a series of 92 patients who underwent surgery for craniopharyngiomas, TSS was the first choice of approach in 57 cases (62%) consisting of 29 female and 28 male patients with ages ranging from 12 to 79 years (mean 35 years). The follow-up duration ranged from 2 to 20 years. A standard transsphenoidal approach was used in patients with an exclusively intrasellar (11 patients) or an intrasellar and suprasellar tumor (37 patients); in nine cases of tumors located exclusively above the sella turcica, a transsphenoidal presellar approach (seven patients) or a transsellar-transdiaphragmatic approach (two patients) was used. Total removal was performed in 36 patients (63%). All patients had good clinical results. Postoperative cerebrospinal fluid leakage occurred in 10 cases, but only one case required a surgical repair of the sella. Two patients died of late complications (3.5%). There were eight cases (14%) of tumor regrowth.
The authors assert that, when used in appropriately located craniopharyngiomas and by neurosurgeons with extensive experience in pituitary surgery, TSS offers excellent results with minor risks.
颅咽管瘤手术治疗的最佳方法仍存在争议。在所有涉及蝶鞍的病例中,作者仅采用经蝶窦手术(TSS),认为该方法比开颅手术创伤小。此外,在一些单纯鞍上颅咽管瘤病例中也采用了TSS。本研究分析了所有接受TSS治疗患者的手术适应证及结果。
在一组92例接受颅咽管瘤手术的患者中,TSS是57例(62%)患者的首选手术方式,其中包括29例女性和28例男性患者,年龄在12至79岁之间(平均35岁)。随访时间为2至20年。对于单纯鞍内(11例)或鞍内及鞍上肿瘤(37例)患者采用标准经蝶窦入路;对于9例仅位于蝶鞍上方的肿瘤患者,采用经蝶窦鞍前入路(7例)或经蝶窦-经鞍膈入路(2例)。36例(63%)患者实现了肿瘤全切。所有患者临床效果良好。术后脑脊液漏发生10例,但仅1例需要进行蝶鞍手术修复。2例患者死于晚期并发症(3.5%)。有8例(14%)肿瘤复发。
作者认为,当应用于位置合适的颅咽管瘤且由垂体手术经验丰富的神经外科医生操作时,TSS风险小且效果良好。